Lineage Cell Therapeutics Provides Update on Renevia® Commercialization Plans

Go back to Lineage Cell Therapeutics Provides Update on Renevia® Commercialization Plans
(NYSE: LCTX) Delayed: 0.96 -0.02 (2.04%)
Previous Close $0.98    52 Week High $ 
Open $0.98    52 Week Low $ 
Day High $1.00    P/E N/A 
Day Low $0.94    EPS $ 
Volume 752,821       

(NYSE: LCTX) Delayed: 0.96 -0.02 (2.04%)
Previous Close $0.98    52 Week High $ 
Open $0.98    52 Week Low $ 
Day High $1.00    P/E N/A 
Day Low $0.94    EPS $ 
Volume 752,821